Neutrophil extracellular trap: A key player in the pathogenesis of autoimmune diseases

Int Immunopharmacol. 2023 Mar:116:109843. doi: 10.1016/j.intimp.2023.109843. Epub 2023 Feb 8.

Abstract

Numerous studies suggest that neutrophils might have a crucial role in the pathogenesis of systemic autoimmune diseases through neutrophil extracellular trap (NET) formation, production of pro-inflammatory cytokines, and organ destruction. NET components that are released into extracellular spaces can be considered autoantigens, which contribute to causing a break in self-tolerance. Subsequently, this leads to the development of autoimmune responses in predisposed individuals. Additionally, an imbalance between NET formation and NET degradation may prolong immune system contact with these modified autoantigens and enhance NET-induced tissue damage. In this review, we discuss the generation and clearance of the NET, as well as the role of NETosis in the pathogenesis of autoimmune disorders, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), multiple sclerosis (MS), psoriasis, antiphospholipid syndrome (APS), and Type-1 diabetes mellitus (T1DM).

Keywords: Autoimmune disease; NETosis; Neutrophil extracellular trap (NET).

Publication types

  • Review

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*
  • Autoantigens
  • Autoimmune Diseases*
  • Extracellular Traps*
  • Humans
  • Lupus Erythematosus, Systemic*
  • Neutrophils

Substances

  • Autoantigens